Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2,6 Diaminopurine Nucleoside. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110759957B reveals a novel KOH-catalyzed route for lipid-soluble isoguanosine intermediates, enhancing bioavailability and reducing purification costs for antisense therapies.